129 related articles for article (PubMed ID: 8577372)
1. Changes in hypothalamic cholecystokininA and cholecystokininB receptor subtypes and associated neuropeptide expression in response to salt-stress in the rat and mouse.
Hinks GL; Poat JA; Hughes J
Neuroscience; 1995 Oct; 68(3):765-81. PubMed ID: 8577372
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons.
Moriarty P; Dimaline R; Thompson DG; Dockray GJ
Neuroscience; 1997 Aug; 79(3):905-13. PubMed ID: 9219953
[TBL] [Abstract][Full Text] [Related]
3. Activity-linked alterations in cholecystokininB receptor messenger RNA levels in magnocellular hypothalamic neurones by food and water deprivation in the rat.
O'Shea RD; Gundlach AL
Neurosci Lett; 1995 Jul; 194(3):189-92. PubMed ID: 7478235
[TBL] [Abstract][Full Text] [Related]
4. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy.
Zhang X; Dagerlind A; Elde RP; Castel MN; Broberger C; Wiesenfeld-Hallin Z; Hökfelt T
Neuroscience; 1993 Nov; 57(2):227-33. PubMed ID: 8115034
[TBL] [Abstract][Full Text] [Related]
5. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.
Luckman SM; Hamamura M; Antonijevic I; Dye S; Leng G
Br J Pharmacol; 1993 Sep; 110(1):378-84. PubMed ID: 8220899
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide gene expression in hypothalamic magnocellular neurons of normal and hypophysectomized rats: a combined immunohistochemical and in situ hybridization study.
Villar MJ; Meister B; Cortés R; Schalling M; Morris M; Hökfelt T
Neuroscience; 1990; 36(1):181-99. PubMed ID: 1699157
[TBL] [Abstract][Full Text] [Related]
8. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism.
Day HE; McKnight AT; Poat JA; Hughes J
Neuropharmacology; 1994 Jun; 33(6):719-27. PubMed ID: 7936109
[TBL] [Abstract][Full Text] [Related]
9. Opiate receptors modulate estrogen-induced cholecystokinin and tachykinin but not enkephalin messenger RNA levels in the limbic system and hypothalamus.
Eckersell CB; Micevych PE
Neuroscience; 1997 Sep; 80(2):473-85. PubMed ID: 9284350
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin B receptor gene expression in hypothalamic neurosecretory neurons after experimental manipulations.
Meister B; Broberger C; Villar MJ; Hökfelt T
Neuroendocrinology; 1994 Nov; 60(5):458-69. PubMed ID: 7845536
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rat.
Presse F; Nahon JL
Neuroscience; 1993 Aug; 55(3):709-20. PubMed ID: 8413933
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
Zarrindast MR; Nikfar S; Rezayat M
Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
[TBL] [Abstract][Full Text] [Related]
13. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
Morency MA; Quirion R; Mishra RK
Neuroscience; 1994 Sep; 62(1):307-16. PubMed ID: 7816208
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin and hypothalamic corticotrophin-releasing factor participate in endotoxin-induced hypophagia.
Rorato R; Reis WL; Antunes-Rodrigues J; Elias LL
Exp Physiol; 2011 Apr; 96(4):439-50. PubMed ID: 21239462
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
Hill DR; Woodruff GN
Brain Res; 1990 Sep; 526(2):276-83. PubMed ID: 2257485
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329.
Hill DR; Shaw TM; Graham W; Woodruff GN
J Neurosci; 1990 Apr; 10(4):1070-81. PubMed ID: 2329368
[TBL] [Abstract][Full Text] [Related]
19. Influence of gastrin on human astrocytic tumor cell proliferation.
Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
[TBL] [Abstract][Full Text] [Related]
20. Functional role of brain CCK receptors.
Woodruff GN; Hill DR; Boden P; Pinnock R; Singh L; Hughes J
Neuropeptides; 1991 Jul; 19 Suppl():45-56. PubMed ID: 1881532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
